Cita APA

Schoffski, P., Heinrich, M., Jones, R., George, S., Gelderblom, H., von Mehren, M., & Serrano, C. (2024). Ripretinib versus sunitinib in gastrointestinal stromal tumor: CtDNA biomarker analysis of the phase 3 INTRIGUE trial.

Citación estilo Chicago

Schoffski, Patrick, Michael Heinrich, Robin Jones, Suzanne George, Hans Gelderblom, Margaret von Mehren, y Cesar Serrano. Ripretinib Versus Sunitinib in Gastrointestinal Stromal Tumor: CtDNA Biomarker Analysis of the Phase 3 INTRIGUE Trial. 2024.

Cita MLA

Schoffski, Patrick, et al. Ripretinib Versus Sunitinib in Gastrointestinal Stromal Tumor: CtDNA Biomarker Analysis of the Phase 3 INTRIGUE Trial. 2024.